Literature DB >> 20069332

Brain MRI screening showing evidences of early central nervous system involvement in patients with systemic sclerosis.

Reem Hamdy A Mohammed1, Yousriah Y Sabry, Amr A Nasef.   

Abstract

Systemic sclerosis is a multisystem autoimmune collagen disease where structural and functional abnormalities of small blood vessels prevail. Transient ischemic attacks, ischemic stroke, and hemorrhage have been reported as primary consequence of vascular central nervous system affection in systemic sclerosis. Magnetic resonance imaging is considered to be the most sensitive diagnostic technique for detecting symptomatic and asymptomatic lesions in the brain in cases of multifocal diseases. The objective of this study is to detect subclinical as well as clinically manifest cerebral vasculopathy in patients with systemic sclerosis using magnetic resonance imaging. As much as 30 female patients with systemic sclerosis aged 27-61 years old, with disease duration of 1-9 years and with no history of other systemic disease or cerebrovascular accidents, were enrolled. Age-matched female control group of 30 clinically normal subjects, underwent brain magnetic resonance examination. Central nervous system (CNS) involvement in the form of white matter hyperintense foci of variable sizes were found in significantly abundant forms in systemic sclerosis patients on magnetic resonance evaluation than in age-related control group, signifying a form of CNS vasculopathy. Such foci showed significant correlation to clinical features of organic CNS lesion including headaches, fainting attacks and organic depression as well as to the severity of peripheral vascular disease with insignificant correlation with disease duration. In conclusion, subclinical as well as clinically manifest CNS ischemic vasculopathy is not uncommon in systemic sclerosis patients and magnetic resonance imaging is considered a sensitive noninvasive screening tool for early detection of CNS involvement in patients with systemic sclerosis.

Entities:  

Mesh:

Year:  2010        PMID: 20069332     DOI: 10.1007/s00296-009-1325-5

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  11 in total

1.  Scleroderma "en coup de sabre": pathological evidence of intracerebral inflammation.

Authors:  J Stone; A J Franks; J A Guthrie; M H Johnson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-03       Impact factor: 10.154

2.  Progressive facial hemiatrophy: central nervous system involvement and relationship with scleroderma en coup de sabre.

Authors:  Maria Blaszczyk; Leszek Królicki; Mateusz Krasu; Olga Glinska; Stefania Jablonska
Journal:  J Rheumatol       Date:  2003-09       Impact factor: 4.666

3.  [Central nervous system involvement in scleroderma].

Authors:  Emmanuel Héron; Anne Hernigou; Paul Fornes; Gilles Chatellier; Joseph Emmerich; Jean-Noël Fiessinger
Journal:  Ann Med Interne (Paris)       Date:  2002-05

Review 4.  The endothelium: its role in scleroderma.

Authors:  J D Pearson
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

5.  White matter hyperintensities on brain magnetic resonance in systemic sclerosis.

Authors:  F Sardanelli; A Iozzelli; B Cotticelli; C Losacco; M Cutolo; A Sulli; F Nobili; G Rodriguez
Journal:  Ann Rheum Dis       Date:  2005-05       Impact factor: 19.103

6.  Intracerebral involvement in scleroderma en coup de sabre: report of a case with neuropathologic findings.

Authors:  M H Chung; J Sum; M J Morrell; D S Horoupian
Journal:  Ann Neurol       Date:  1995-05       Impact factor: 10.422

7.  Evidence of cerebral hypoperfusion in scleroderma patients.

Authors:  M Cutolo; F Nobili; A Sulli; C Pizzorni; M Briata; F Faelli; P Vitali; G Mariani; F Copello; B Seriolo; C Barone; G Rodriguez
Journal:  Rheumatology (Oxford)       Date:  2000-12       Impact factor: 7.580

8.  Scleroderma and central nervous system vasculitis.

Authors:  R Pathak; A J Gabor
Journal:  Stroke       Date:  1991-03       Impact factor: 7.914

9.  Mechanisms of endothelial cell damage in systemic sclerosis and Raynaud's phenomenon.

Authors:  A D Blann; K Illingworth; M I Jayson
Journal:  J Rheumatol       Date:  1993-08       Impact factor: 4.666

10.  Multiple spontaneous intracerebral hemorrhages in a patient with progressive systemic sclerosis.

Authors:  A P Andonopoulos; T Maraziotis; G Rigas; S Yarmenitis; T Papapetropoulos
Journal:  Rev Rhum Engl Ed       Date:  1998-06
View more
  5 in total

1.  Seizures in systemic sclerosis.

Authors:  Fernando Glasner Araújo; Tiago Nardi Amaral; Simone Appenzeller; Jozélio Freire de Carvalho
Journal:  Rheumatol Int       Date:  2012-12-29       Impact factor: 2.631

2.  X chromosome gene methylation in peripheral lymphocytes from monozygotic twins discordant for scleroderma.

Authors:  C Selmi; C A Feghali-Bostwick; A Lleo; S A Lombardi; M De Santis; F Cavaciocchi; L Zammataro; M M Mitchell; J M Lasalle; T Medsger; M E Gershwin
Journal:  Clin Exp Immunol       Date:  2012-09       Impact factor: 4.330

Review 3.  Acute cerebral vasculopathy in systemic sclerosis.

Authors:  Benoit Faucher; Brigitte Granel; Francois Nicoli
Journal:  Rheumatol Int       Date:  2012-12-23       Impact factor: 2.631

4.  Systemic sclerosis associated with colliquative necrosis in the cerebellum.

Authors:  Alessandro Ricci; Hambra Di Vitantonio; Danilo De Paulis; Mattia Del Maestro; Soheila Raysi Dehcordi; Domenico Murrone; Gino Coletti; Giuseppe Calvisi; Renato Juan Galzio
Journal:  Surg Neurol Int       Date:  2017-04-05

5.  Study of MRI brain findings and carotid US features in systemic sclerosis patients, relationship with disease parameters.

Authors:  Rania M Gamal; Hanan Sayed M Abozaid; Mohmed Zidan; Mohamed Aboel-Kassem F Abdelmegid; Mohmed Raouf Abdel-Razek; Sahar Abdel-Rahman Alsayed; Amr F Mourad; Nashwa Mostafa A Azoz; Lobna Abdel-Wahid Mohram; Daniel E Furst
Journal:  Arthritis Res Ther       Date:  2019-04-15       Impact factor: 5.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.